AKCESO RECENT NEWS
28th June 2016: Akceso attends EU Health Parliament.
Akceso was invited to attend the final session of the 2016 EU Health Parliament in Brussels. The meeting providied an opportunity for a set of 5 key challenges to be presented to senior EU health leaders. See the EU Health Parliament web site for details.
20th April 2016: Akceso presenting at Duale Hochschule Baden-Württemberg on April 20th
Dr. András Incze, CEO of Akceso Advisors, will be speaking on the topic of 'An Emerging Pricing Ethic in Pharma - after Sovaldi, Valeant and Turing Pharma' at the DHBW in Lörrach, as part of their series 'Conversations on Healthcare Themes'.
A preview article is available here in German.
Contact Kinga Brady for more information
25th February 2016: Inaugural Akceso Network Event for Payors & Executives.
Akceso hosted a discussion meeting in Zurich for senior payors and selected pharma Pricing & Market Access executives. Our keynote speaker is Dr. Tomás Tesar, member of the Working Group for Pharmacoeconomics, Clinical Outcomes and Health Technology Assessment of the Slovak MoH, representative of Slovakia in EUnetHTA. Mr Tesar will speak about “Public funding sustainability trends – in light of new costly drugs
(for daily news please go to Akceso's Twitter Page)
June 23rd - Report Shows UK Behind EU For Access to Cancer Drugs
The Swedish Institute for Health Economics' recent report has a much slower uptake of new cancer medicines than comparable economies in the Europe.
April 30th - Report Hightlights Impact of Pricing Policy on Innovation
A new report by independent think tank the Information Technology & Innovation Foundation has highlighted the impact of national pricing policies on pharmaceutical innovation, exploring key indicators across over 50 countries.
March 24th - New EU Report on Reference Pricing
A new EU report provides an in-depth review of pharmaceutcial pricing practices in Europe, with a particular focus on International Reference Pricing.